scholarly journals Validated LC‐MS/MS method of Sphingosine 1‐phosphate quantification in human serum for evaluation of response to radiotherapy in lung cancer

2020 ◽  
Vol 11 (6) ◽  
pp. 1443-1452 ◽  
Author(s):  
Xiaohui Tang ◽  
Haisheng Chen ◽  
Guanxuan Chen ◽  
Cunxian Duan ◽  
Qing Fan ◽  
...  
2018 ◽  
Vol 38 (5) ◽  
Author(s):  
Yuko Mishima ◽  
Makoto Kurano ◽  
Tamaki Kobayashi ◽  
Masako Nishikawa ◽  
Ryunosuke Ohkawa ◽  
...  

Dihydro-sphingosine 1-phosphate (DH-S1P) is an analog of sphingosine 1-phosphate (S1P), which is a potent lysophospholipid mediator. DH-S1P has been proposed to exert physiological properties similar to S1P. Although S1P is known to be carried on HDL via apolipoprotein M (apoM), the association between DH-S1P and HDL/apoM has not been fully elucidated. Therefore, in the present study, we aimed to elucidate this association and to compare it with that of S1P and HDL/apoM. First, we investigated the distributions of S1P and DH-S1P among lipoproteins and lipoprotein-depleted fractions in human serum and plasma samples and observed that both S1P and DH-S1P were detected on HDL; furthermore, elevated amounts of DH-S1P in serum samples were distributed to the lipoprotein-depleted fraction to a greater degree than to the HDL fraction. Concordantly, a preference for HDL over albumin was only observed for S1P, and not for DH-S1P, when the molecules were secreted from platelets. Regarding the association with HDL, although both S1P and DH-S1P prefer to bind to HDL, HDL preferentially accepts S1P over DH-S1P. For the association with apoM, S1P was not detected on HDL obtained from apoM knockout mice, while DH-S1P was detected. Moreover, apoM retarded the degradation of S1P, but not of DH-S1P. These results suggest that S1P binds to HDL via apoM, while DH-S1P binds to HDL in a non-specific manner. Thus, DH-S1P is not a mere analog of S1P and might possess unique clinical significance.


2019 ◽  
Vol 234 (12) ◽  
pp. 23798-23806 ◽  
Author(s):  
Mariarosaria Boccellino ◽  
Federica Pinto ◽  
Vincenzo Ieluzzi ◽  
Alfonso Giovane ◽  
Lucio Quagliuolo ◽  
...  

PLoS ONE ◽  
2013 ◽  
Vol 8 (3) ◽  
pp. e60134 ◽  
Author(s):  
Julien Mazières ◽  
Caroline Catherinne ◽  
Olivier Delfour ◽  
Sandrine Gouin ◽  
Isabelle Rouquette ◽  
...  

2020 ◽  
Vol 1137 ◽  
pp. 121913 ◽  
Author(s):  
Brigitta Mészáros ◽  
Gábor Járvás ◽  
Anna Farkas ◽  
Márton Szigeti ◽  
Zsuzsanna Kovács ◽  
...  

2005 ◽  
Vol 53 (9) ◽  
pp. 1159-1166 ◽  
Author(s):  
Korey R. Johnson ◽  
Kristy Y. Johnson ◽  
Heather G. Crellin ◽  
Besim Ogretmen ◽  
Alice M. Boylan ◽  
...  

Sphingosine kinase 1 (SK1) is a key enzyme critical to the sphingolipid metabolic pathway responsible for catalyzing the formation of the bioactive lipid sphingosine-1-phosphate. SK1-mediated production of sphingosine-1-phosphate has been shown to stimulate such biological processes as cell growth, differentiation, migration, angiogenesis, and inhibition of apoptosis. In this study, cell type–specific immunolocalization of SK1 was examined in the bronchus/terminal bronchiole of the lung. Strong immunopositive staining was evident at the apical surface of pseudostratified epithelial cells of the bronchus and underlying smooth muscle cells, submucosal serous glands, immature chondrocytes, type II alveolar cells, foamy macrophages, endothelial cells of blood vessels, and neural bundles. Immunohistochemical screening for SK1 expression was performed in 25 samples of normal/tumor patient matched non–small-cell lung cancer tissue and found that 25 of 25 tumor samples (carcinoid [5 samples], squamous [10 samples], and adenocarcinoma tumors [10 samples]), exhibited overwhelmingly positive immunostaining for SK1 as compared with patient-matched normal tissue. In addition, an approximately 2-fold elevation of SK1 mRNA expression was observed in lung cancer tissue versus normal tissue, as well as in several other solid tumors. Taken together, these findings define the localization of SK1 in lung and provide clues as to how SK1 may play a role in normal lung physiology and the pathophysiology of lung cancer.


2016 ◽  
Vol 4 (10) ◽  
pp. 1811-1817 ◽  
Author(s):  
Chunyuan Song ◽  
Yanjun Yang ◽  
Boyue Yang ◽  
Linghua Min ◽  
Lianhui Wang

A highly sensitive and specific SERS-based combination assay of lung cancer associated serum markers is reported, and the LODs of CEA and NSE in human serum specimens are 1.48 pg mL−1 and 2.04 pg mL−1, respectively.


Sign in / Sign up

Export Citation Format

Share Document